Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

China · Delayed Price · Currency is CNY

13.61

-0.17 (-1.23%)

Sep 10, 2026, 1:45 PM CST

Market Cap	7.60B -38.8%
Revenue (ttm)	9.93B -2.9%
Net Income	69.63M
EPS	0.13
Shares Out	551.42M
PE Ratio	107.86
Forward PE	27.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,927,508
Open	13.70
Previous Close	13.78
Day's Range	13.44 - 13.73
52-Week Range	11.56 - 22.77
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; an... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1979

Employees 10,864

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600129

Full Company Profile

Financial Performance

In 2025, SHA:600129's revenue was 10.50 billion, a decrease of -15.23% compared to the previous year's 12.39 billion. Earnings were 120.57 million, an increase of 352.37%.

Financial Statements